Published in Eye (Lond) on August 24, 2007
Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review. Clin Ophthalmol (2008) 0.82
Cost effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom using a decision-analytic health economic model. Eye (Lond) (2009) 0.75
Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany. Int J Ophthalmol (2013) 0.75
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
Rubella hemagglutinin prepared with alkaline extraction of virus grown in suspension culture of BHK-21 cells. Proc Soc Exp Biol Med (1967) 5.61
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA (1988) 3.89
Measles antibody: reevaluation of protective titers. J Infect Dis (1990) 3.77
Isolation and identification of Haemophilus ducreyi in a clinical study. J Clin Microbiol (1980) 3.40
Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells. Ann Med Exp Biol Fenn (1967) 2.89
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. Neurology (2006) 2.75
The microbiological flora of penile ulcerations. J Infect Dis (1978) 2.43
Indirect hemagglutination test for detection of antibodies to Cytomegalovirus. Appl Microbiol (1971) 2.28
Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%. Am J Ophthalmol (2001) 2.06
Multidisciplinary approach to deep-seated lesions requiring radiologically-guided fine-needle aspiration. Diagn Cytopathol (1998) 2.04
Cytomegalovirus specific IgM and IgG response in humans studied by radioimmunoassay. J Immunol (1976) 2.03
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83
Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med (1975) 1.80
A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA (1987) 1.75
Method for typing antisera to Herpesvirus hominis by indirect hemagglutination inhibition. Appl Microbiol (1971) 1.70
How reliable is the morphological diagnosis of penile ulcerations? Sex Transm Dis (1978) 1.70
Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J Clin Microbiol (1991) 1.68
Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med (1973) 1.65
Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis (1995) 1.60
Combined doppler and phased-array echocardiographic estimation of cardiac output. Circulation (1981) 1.57
Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry. Eye (Lond) (2009) 1.57
Experimental alveolar lipo-proteinosis following the inhalation of silica. J Pathol (1970) 1.56
Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis (1991) 1.50
Rubella complement fixing antigen prepared by alkaline extraction of virus grown in suspension culture of BHK-211 cells. Proc Soc Exp Biol Med (1967) 1.49
The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia (1984) 1.48
Doctors who do not feel sober enough to drive should avoid helping in medical emergencies. BMJ (1998) 1.47
Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax (1994) 1.46
Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology (1986) 1.43
Detection of persistent left superior vena cava by two-dimensional contrast echocardiography. J Clin Ultrasound (1979) 1.42
Mammography after treatment for breast cancer. BMJ (1994) 1.40
Beyond code teams: early defibrillation by nurses for in-hospital cardiac arrests. J Emerg Nurs (1992) 1.39
Cerebrovascular risk factors and stroke subtypes: differences between ethnic groups. Stroke (2001) 1.39
Optimizing "delay period" for burst stimulation in dynamic cardiomyoplasty. Ann Thorac Surg (1995) 1.38
Echocardiographic documentation of vegetative lesions in infective endocarditis: clinical implications. Circulation (1980) 1.32
Cytomegalovirus mononucleosis in a first trimester pregnant female with transmission to the fetus. Pediatrics (1971) 1.31
Evaluation of serological techniques for titration of rubella antibody. Am J Public Health Nations Health (1969) 1.29
The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye (Lond) (2006) 1.26
Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol (1998) 1.25
Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993. MMWR CDC Surveill Summ (1997) 1.25
Primary cytomegalovirus and opportunistic infections. Incidence in renal transplant recipients. JAMA (1978) 1.24
Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J Clin Microbiol (1990) 1.23
Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen. J Clin Microbiol (1999) 1.22
Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J (1991) 1.20
Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands. JAMA (1988) 1.18
Guidelines for the prevention and treatment of B-virus infections in exposed persons. The B virus Working Group. Clin Infect Dis (1995) 1.18
Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis (1997) 1.17
National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 2. Laboratory results. Ann Intern Med (1983) 1.16
Retracted Is Kaposi's-sarcoma-associated herpesvirus detectable in semen of HIV-infected homosexual men? Lancet (1995) 1.11
Herpesvirus simiae contamination of primary rhesus monkey kidney cell cultures. CDC recommendations to minimize risks to laboratory personnel. Diagn Microbiol Infect Dis (1990) 1.10
Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects. Eye (Lond) (2004) 1.08
Helicobacter pylori cagA status, vacA genotypes and ulcer disease. Eur J Gastroenterol Hepatol (1998) 1.05
Highly potent neurotensin analog that causes hypothermia and antinociception. Eur J Pharmacol (2000) 1.04
Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery. Arch Ophthalmol (1997) 1.03
Transient monoclonal gammopathy associated with cytomegalovirus infection. Blood (1974) 1.02
Surveillance of congenital cytomegalovirus disease, 1990-1991. Collaborating Registry Group. MMWR CDC Surveill Summ (1992) 1.02
Herpesvirus antibody levels in the etiologic diagnosis of the acute retinal necrosis syndrome. Am J Ophthalmol (1992) 1.02
Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma. J Med Virol (2004) 1.02
Immune-complex glomerulonephritis associated with cytomegalovirus infection. Am J Clin Pathol (1979) 1.00
Hemiparasitic plant impacts animal and plant communities across four trophic levels. Ecology (2015) 0.99
Evaluation of immunoassays for detection of antibodies to human herpesvirus 7. Clin Diagn Lab Immunol (1996) 0.99
The significance of cagA and vacA subtypes of Helicobacter pylori in the pathogenesis of inflammation and peptic ulceration. J Clin Pathol (1998) 0.98
The effects of unoprostone isopropyl 0.12% and timolol maleate 0.5% on diurnal intraocular pressure. J Glaucoma (1998) 0.98
B16 murine melanoma and aging: slower growth and longer survival in old mice. J Natl Cancer Inst (1984) 0.97
Nosocomial herpetic infections in a pediatric intensive care unit. Am J Epidemiol (1981) 0.96
The epidemiology of infection with the human herpesviruses in Navajo children. Am J Epidemiol (1988) 0.96
Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J Immunol (1996) 0.96
A localized stimulation of lens protein synthesis by actinomycin D. Biochim Biophys Acta (1966) 0.95
Association between BoLA and subclinical bovine leukemia virus infection in a herd of Holstein-Friesian cows. Immunogenetics (1988) 0.95
Cytomegaloviral infection and disease. J Infect Dis (1985) 0.95
Provocation-neutralization: a two-part study. Part II. Subcutaneous neutralization therapy: a multi-center study. Otolaryngol Head Neck Surg (1988) 0.95
Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression. Proc Natl Acad Sci U S A (1999) 0.94
Rubella in Trinidad: sero-epidemiologic studies of an institutional outbreak. Am J Epidemiol (1969) 0.94
Seroepidemiology of chronic fatigue syndrome: a case-control study. Clin Infect Dis (1995) 0.94
A comparative trial of desipramine and nortriptyline in depression. Br J Psychiatry (1968) 0.94
Nonradioactive PCR-enzyme-linked immunosorbent assay method for detection of human cytomegalovirus DNA. J Clin Microbiol (1995) 0.94
AIDS dementia complex complicated by cytomegalovirus encephalopathy. J Neurol (1993) 0.93
Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysis. J Pediatr (1985) 0.93
Assessment of bleomycin lung toxicity using angiotensin-converting enzyme in pulmonary lavage. Cancer Res (1980) 0.92
Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood (1996) 0.92
Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost. Am J Ophthalmol (1999) 0.92
Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure. Am J Ophthalmol (2000) 0.92
Effect of timolol 0.5% gel and solution on pulmonary function in older glaucoma patients. J Glaucoma (2001) 0.92
Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy. Eye (Lond) (2004) 0.91
Long-term progression at individual mean intraocular pressure levels in primary open-angle and exfoliative glaucoma. Eur J Ophthalmol (2008) 0.91
Detection of Epstein-Barr virus-specific antibodies by means of baculovirus-expressed EBV gp125. J Virol Methods (1995) 0.91
The immunocytochemical demonstration of renin in a juxtaglomerular cell tumour by light and electron microscopy. Histopathology (1983) 0.91
In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier. Neuropharmacology (1999) 0.89
Antithrombotic and antihypertensive management 3 months after ischemic stroke : a prospective study in an inner city population. Stroke (2000) 0.89
Epidural anesthesia for obstetrics after spinal surgery. Reg Anesth (1991) 0.88
Lactate dehydrogenase isozymes and their relationship to lens cell differentiation. Biochim Biophys Acta (1966) 0.88
Peripheral B lymphocyte percentage as an indicator of subclinical progression of bovine leukemia virus infection. J Dairy Sci (1988) 0.88
Acute retinal necrosis syndrome following herpes zoster dermatitis. Ophthalmology (1986) 0.87
Safety and efficacy of bimatoprost 0.03% versus timolol maleate 0.5%/dorzolamide 2% fixed combination. Eur J Ophthalmol (2005) 0.87
Cytomegalovirus seroprevalence in women bearing children in Jefferson County, Kentucky. Am J Med Sci (1993) 0.87
Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study. Am J Med (1986) 0.87
A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med (1993) 0.86